Lv3
266 积分 2023-07-02 加入
Successful therapy for pyoderma gangrenosum with a Janus kinase 2 inhibitor
9小时前
已完结
Expert consensus on the treatment of dermatoses with targeted drugs (2025 version)
1天前
已完结
Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases
2天前
已完结
Baricitinib in the treatment of adults with pyoderma gangrenosum: An open-label pilot trial
2天前
求助中
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
2天前
已完结
Tofacitinib as a possible treatment for skin thickening in diffuse cutaneous systemic sclerosis
3天前
已完结
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
3天前
已完结
[Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition)]
3天前
已完结
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex
3个月前
已完结
Real-world characteristics of Janus kinase inhibitor-associated acne: A 14-year retrospective cohort study
3个月前
已关闭
皖公网安备34019202002308
